Larimar Therapeutics, Inc. (NASDAQ:LRMR – Free Report) was the target of a large drop in short interest in June. As of June 15th, there was short interest totalling 149,900 shares, a drop of 23.9% from the May 31st total of 197,000 shares. Based on an average daily volume of 313,700 shares, the days-to-cover ratio is […]
Larimar Therapeutics Set to Join Russell 3000® Index itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.
Larimar Therapeutics Set to Join Russell 3000® Index tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
21.06.2023 - BALA CYNWYD, Pa., June 21, 2023 (GLOBE NEWSWIRE) - Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today announced that it is set to join the . Seite 1
Larimar Therapeutics, Inc. (NASDAQ:LRMR – Get Rating) – Equities research analysts at William Blair issued their Q1 2025 earnings per share (EPS) estimates for Larimar Therapeutics in a report released on Tuesday, May 16th. William Blair analyst M. Minter forecasts that the company will earn ($0.22) per share for the quarter. The consensus estimate for […]